adalimumab-aqvh

CHEBI:CHEBI_752281

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2640400
pharm_class
Monoclonal [CS]
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
labeler_name
Coherus BioSciences Inc
manufacturer_name
Coherus BioSciences Inc
marketing_category
BLA
marketing_start_date
20230701
package_marketing_start_date
20230701
active_ingredient_name
ADALIMUMAB
active_ingredient_strength
40 mg/.8mL
unii
FYS6T7F842
nui
M0001357
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_cs
Antibodies, Monoclonal [CS]
generic_name
adalimumab-aqvh
brand_name
YUSIMRY
brand_name_base
YUSIMRY
product_ndc
71288-815
application_number
BLA761216
spl_id
fb8b9ab3-f056-46f5-8211-f0923e6b2655
package_ndc
71288-815-81
package_description
2 SYRINGE, GLASS in 1 CARTON (71288-815-81) / .8 mL in 1 SYRINGE, GLASS
spl_set_id
4cab600d-6950-409f-a6d8-d447da22cd95
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class